Literature DB >> 34652440

Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin.

Rajni Kant1, Gaurav Dwivedi1, Kamran Zaman1, Rima R Sahay2, Gajanan Sapkal2, Himanshu Kaushal2, Dimpal A Nyayanit2, Pragya D Yadav2, Gururaj Deshpande2, Rajeev Singh1, Sandeep Chaowdhary3, Nivedita Gupta4, Sanjay Kumar5, Priya Abraham2, Samiran Panda4, Balram Bhargava4.   

Abstract

Entities:  

Keywords:  Covaxin; Covishield; Heterologous regime; Immunogenecity; SARS-CoV-2

Mesh：

Substances：

Year:  2021        PMID： 34652440      PMCID： PMC8524638          DOI： 10.1093/jtm/taab166

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  6 in total

Review 1.  COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.

Authors:  Suhad Daher-Nashif; Rania Al-Anany; Menatalla Ali; Khadija Erradi; Elmoubasher Farag; Abdallah M Abdallah; Mohamed M Emara
Journal:  Arch Virol       Date:  2022-06-20       Impact factor: 2.685

Review 2.  Covaxin: An overview of its immunogenicity and safety trials in India.

Authors:  Rohit Sharma; Swati Tiwari; Aparna Dixit
Journal:  Bioinformation       Date:  2021-10-31

3.  SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India.

Authors:  Sumit Malhotra; Kalaivani Mani; Rakesh Lodha; Sameer Bakhshi; Vijay Prakash Mathur; Pooja Gupta; Saurabh Kedia; Jeeva Sankar; Parmeshwar Kumar; Arvind Kumar; Vineet Ahuja; Subrata Sinha; Randeep Guleria; Aman Dua; Shafi Ahmad; Ramadass Sathiyamoorthy; Ajay Sharma; Tabbu Sakya; Vikas Gaur; Shilpi Chaudhary; Swetambri Sharma; Divya Madan; Anvita Gupta; Shubi Virmani; Arti Gupta; Nidhi Yadav; Surbhi Sachdeva; Shilpi Sharma; Sachin Singh; Abhimanyu Pandey; Mukesh Singh; Divashree Jhurani; Swarnabha Sarkar; Amol Kumar Lokade; Atif Mohammad; Sabitri Pandit; Ritu Dubey; Ajay Kumar Singh; Naveen Gohar; Divyansh Soni; Arunangshu Bhattacharyya; Sabin Rai; Snikitha Tummala; Ishan Gupta; Sakshi Shukla
Journal:  JAMA Netw Open       Date:  2022-01-04

4.  Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?

Authors:  Om Prakash Choudhary; Jivan Q Ahmed; Teroj A Mohammed; Indraj Singh; Alfonso J Rodriguez-Morales
Journal:  Hum Vaccin Immunother       Date:  2021-12-13       Impact factor: 3.452

5.  Inactivated vaccine Covaxin/BBV152: A systematic review.

Authors:  Tousief Irshad Ahmed; Saqib Rishi; Summaiya Irshad; Jyoti Aggarwal; Karan Happa; Sheikh Mansoor
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

Review 6.  A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects.

Authors:  Farokh Dotiwala; Arun K Upadhyay
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.